Aardvark Therapeutics, Inc. Common Stock

Estimate an entry price from future earnings and your required return. Growth and the exit P/E change the forecast; current earnings yield uses only EPS and the price used.

Trailing four-quarter earnings were negative. Enter a positive EPS override, an exit P/E and an EPS growth assumption to calculate a forecast.

EPS basis: trailing four-quarter earnings were negative, so there is no reported EPS to use. Current earnings yield: N/M. Dividends are excluded from projected annual return.